Bluestem Biosciences, an Omaha, NE-based renewable chemicals company, raised $5M in Pre-Seed funding.
The round was led by Zero Infinity Partners with participation from Matt Vining, Invest Nebraska, Robert Sali, and Bluestem CEO Billy Hagstrom.
The company intends to use the funds to build a team and product discovery pipeline powered by its proprietary digital biology architecture.
Co-founded by Hagstrom and Tyler Autera, CTO, Bluestem Biosciences is leveraging digital biology to facilitate the discovery of biomanufacturing, focused on the sustainable production of decarbonized bio-chemicals. Founded in January 2022, the company is focused on the sustainable bio-production of chemicals through anaerobic fermentation with an identified path toward industrial scale.
Bluestem has announced its Strategic Advisory Board, including:
- Jed Dean, PhD – Former Co-Founder of Zymergen
- Alex Greenbaum – Partner of EQT Group (Infrastructure)
- Kristy Hawkins, PhD – Co-Founder & CSO, Antheia
- John Kwaak – Founder & Managing Partner, Zero Infinity Partners
- Ton Van Maris, PhD – Professor at KTH Royal Institute of Technology
- Matt Vining – CEO, Navigator CO2 Ventures
FinSMEs
09/08/2022